ISLAMABAD: The Ministry of National Health Services on Monday said the first batch of China’s single-dose CanSino COVID-19 vaccine would be available for administration to the citizens by the end of May after thorough rigorous quality control checks.
According to an official of the ministry, the first batch of bulk CanSino vaccine is being processed at the National Institute of Health’s plant, which was set up for this purpose in April, and a specially trained team is working on it.
He said due to the agreement on technology transfer, the National Institute of Health would be able to produce three million doses per month which would significantly reduce the country’s dependence on other countries.
On May 21, the National Assembly was informed that Pakistan had started local production of anti-Covid vaccine.
Parliamentary Secretary for National Health Services Nausheen Hamid had told the House during question hour that the first batch of CanSino vaccine was currently being manufactured at the National Institute of Health (NIH) and it would be available for administration to the people very soon.